1. Home
  2. OVBC vs SABS Comparison

OVBC vs SABS Comparison

Compare OVBC & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$44.26

Market Cap

188.7M

Sector

Finance

ML Signal

N/A

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
SABS
Founded
1872
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
201.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
OVBC
SABS
Price
$44.26
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.80
AVG Volume (30 Days)
8.3K
822.8K
Earning Date
04-24-2026
05-08-2026
Dividend Yield
2.07%
N/A
EPS Growth
42.67
N/A
EPS
3.31
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.94
$1.09
52 Week High
$44.99
$6.60

Technical Indicators

Market Signals
Indicator
OVBC
SABS
Relative Strength Index (RSI) 66.37 43.96
Support Level $39.07 $3.69
Resistance Level $44.73 $4.16
Average True Range (ATR) 1.16 0.16
MACD 0.31 -0.01
Stochastic Oscillator 85.88 20.97

Price Performance

Historical Comparison
OVBC
SABS

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: